Reproterol
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 54063-54-6 |
| ATC code | R03AC15 |
| PubChem | CID 25654 |
| UNII | 11941YC6RN  |
| KEGG | D08474 |
| Chemical data | |
| Formula | C18H23N5O5 |
| Mol. mass | 389.406 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Reproterol (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]
[edit] References
- ^ Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735
|
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
